Zobrazeno 1 - 10
of 773
pro vyhledávání: '"quadrivalent vaccine"'
Publikováno v:
Expert Review of Vaccines, Vol 22, Iss 1, Pp 608-619 (2023)
Background Between 2015 and 2019, when 62% of Belgian adults aged ≥65 years were vaccinated with standard quadrivalent influenza vaccines, influenza caused an average of 3,905 hospitalizations and 347 premature deaths per year in older adults. The
Externí odkaz:
https://doaj.org/article/92a2ec64044b4b94a6dc43a5ea38ee7a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 2 (2023)
A recent study by Zimmerman et al. (2023) reported non-significant higher relative vaccine effectiveness of recombinant (RIV4) over the standard-dose influenza vaccines (SDIV) against outpatient illness during the 2018–19 and 2019–20 vaccination
Externí odkaz:
https://doaj.org/article/6dd54ec73254419e8db055e43573041e
Autor:
K. V. Zhdanov, K. Kasyanenko, O. V. Mal'cev, N. I. L'vov, D. A. Lioznov, I. I. Lapikov, K. S. Ivanov
Publikováno v:
Эпидемиология и вакцинопрофилактика, Vol 21, Iss 5, Pp 98-106 (2022)
Relevance. Seasonal flu vaccination is still the most effective way to protect against flu viruses and help to reduce the burden of flu illnesses. Another possible benefit is the impact of yearly vaccines on severity of breakthrough infection. In thi
Externí odkaz:
https://doaj.org/article/6a1a94de3bac4661838b28123784bb69
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 5 (2022)
A recent study reported that the high-dose quadrivalent influenza vaccine provided superior immunogenicity and efficacy versus the standard-dose quadrivalent vaccine in the elderly. However, we need to view these results in terms of public health ben
Externí odkaz:
https://doaj.org/article/7fb7947901144b1284662f2cbd7108d2
Publikováno v:
BMC Women's Health, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Introduction Available human papillomavirus (HPV) vaccines could have an important primary role in cervical cancer prevention once their long-term immunogenicity and safety are evaluated at the population level. The aim of this study was to
Externí odkaz:
https://doaj.org/article/626e2518968b4bf9ae6772995eb0737a
Autor:
Alltalents T. Murahwa, Tinashe Mudzviti, Racheal S. Dube Mandishora, Takudzwa Chatindo, Peace Chanetsa, Margaret Pascoe, Tinei Shamu, Wisdom Basera, Ruedi Luethy, Anna-Lise Williamson
Publikováno v:
Viruses, Vol 16, Iss 1, p 162 (2024)
Background: Human papillomavirus (HPV) vaccination programs are a key intervention in protecting individuals against HPV-related disease. HIV1-infected individuals are at increased risk of HPV-associated cancers. This study was conducted to evaluate
Externí odkaz:
https://doaj.org/article/c3a521a79413459881597c433fd69674
Autor:
Pablo Manuel Bianculli, Lucile Bellier, Ignacio Olivera Mangado, Carlos Grau Pérez, Gustavo Mieres, Luis Lazarov, Audrey Petitjean, Hugo Dibarboure, Juan Guillermo Lopez
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 5 (2022)
We evaluated the cost-utility of replacing trivalent influenza vaccine (TIV) with quadrivalent influenza vaccine (QIV) in the current target populations in Uruguay. An existing decision-analytic static cost-effectiveness model was adapted for Uruguay
Externí odkaz:
https://doaj.org/article/b381410b7c294b738af69cada6ddb5a6
Autor:
Antonio Arbo, Celia Martinez-Cuellar, Cynthia Vazquez, Lucile Bellier, Cecilia Adorno, Hugo Dibarboure, Juan Guillermo Lopez, Audrey Petitjean, Pablo Bianculli
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 5 (2022)
This study aimed to investigate the public health and economic benefit of using a quadrivalent influenza vaccine (QIV) instead of a trivalent influenza vaccine (TIV) in past seasons in Paraguay. The budget impact of switching from TIV to QIV in the I
Externí odkaz:
https://doaj.org/article/f8099cd98bb742bca78d871338360d55
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.